Amanta Healthcare Limited (AMANTA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE084K01015
Key metrics
- Market Cap
- ₹719 Cr
- P/E Ratio
- 48.97
- EPS
- 3.78
- Book Value
- 56.71
- P/B Ratio
- 3.26
- ROE
- 6.75%
- ROCE
- 8.85%
- Debt / Equity
- 1.11
- Net Margin
- 5.17%
- Revenue Growth
- 4.72%
- Profit Growth
- 41.66%
- Dividend Yield
- —
- 52W High
- ₹205.57
- 52W Low
- ₹92.00
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Amanta Healthcare Limited
Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare Limited was incorporated in 1994 and is headquartered in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Employees
- 460
- Promoter Holding
- 68.4%
The full Amanta Healthcare Limited analysis
Create a free account to open the complete AMANTA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.